Pharmacotherapeutic environments for substance use disorders

Am J Drug Alcohol Abuse. 2007;33(5):627-9. doi: 10.1080/00952990701578676.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Ambulatory Care
  • Buprenorphine / therapeutic use
  • Cognitive Behavioral Therapy
  • Delayed-Action Preparations
  • Family Practice
  • Heroin Dependence / drug therapy
  • Heroin Dependence / rehabilitation
  • Hospitalization
  • Humans
  • Methadone / therapeutic use
  • Naltrexone / therapeutic use
  • Office Visits
  • Opioid-Related Disorders / drug therapy
  • Opioid-Related Disorders / rehabilitation
  • Secondary Prevention
  • Substance-Related Disorders / drug therapy*
  • Substance-Related Disorders / rehabilitation

Substances

  • Delayed-Action Preparations
  • Buprenorphine
  • Naltrexone
  • Methadone